Dyronib 50mg Tablet
Marketer
Hetero Healthcare Limited
Salt Composition
Dasatinib (50mg)
Overview Dyronib 50mg Tablet
Leukaemia medication, Dyronib 50mg tablets, combats chronic myeloid leukaemia. Prescribed for patients unresponsive to or intolerant of alternative leukaemia treatments, it may be taken with or without food, but consistently at the same time daily for optimal efficacy. Dosage and frequency are determined by your physician based on individual needs and may vary. Strict adherence to the prescribed regimen is crucial; incorrect usage or overdose can lead to severe adverse effects. Therapeutic benefits may not be immediately apparent, requiring weeks or months. Discontinuation should only occur under medical supervision. Common side effects include nausea, vomiting, stomach pain, and skin rash. Increased heart rate and blood pressure fluctuations are possible; consult your doctor if these occur. Regular blood pressure monitoring may be implemented. Avoid antacids within two hours of administration. Dyronib 50mg can lower blood cell counts, raising infection risk; regular blood tests are essential. Inform your healthcare provider of all medications, as interactions are possible. Use during pregnancy or breastfeeding is contraindicated. Refrain from driving if dizziness or blurred vision develops.
Uses of Dyronib 50mg Tablet
Chronic myeloid leukemia, a type of blood malignancy
Major Benefits of Dyronib 50mg Tablet:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the 50mg Dyronib Tablet whole; do not chew, crush, or divide it. While it can be taken with or without food, consistent timing is recommended.
Common Side effects of Dyronib 50mg Tablet:
- Abdominal pain
- Anemia (low number of red blood cells)
- Breathing problems
- Fatigue
- Fever
- Headache
- Infection
- Low blood platelets
- Musculoskeletal (bone, muscle or joint) pain
- Nausea
- Rash
- Vomiting
How to use Dyronib 50mg Tablet:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Swallow the Dyronib 50mg Tablet whole; do not break, crush, or chew it. This medication can be taken with or without food, however, consistency in timing is recommended.
How Dyronib 50mg Tablet works:
Cancer treatment Dyronib 50mg tablets inhibit the activity of a faulty protein responsible for cancer cell proliferation, thereby curbing or slowing tumor growth.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption with Dyronib 50mg tablets may pose unknown risks. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Using Dyronib 50mg tablets during pregnancy poses a confirmed risk to the fetus. Its use should be avoided except in critical circumstances where a physician deems the potential benefits outweigh the known hazards. Always seek medical advice.
Breast feedingUNSAFE
Lactation and Dyronib 50mg tablets are incompatible. Evidence indicates a potential for infant toxicity with this medication.
DrivingUNSAFE
Dyronib 50mg tablets can induce adverse reactions that may impair driving ability. Exercise caution while operating a vehicle if dizziness or blurred vision occurs after taking Dyronib 50mg.
KidneySAFE IF PRESCRIBED
The use of Dyronib 50mg tablets in individuals with kidney impairment appears to present minimal risk. Current evidence indicates dose modification may be unnecessary; however, physician consultation is recommended.
LiverSAFE IF PRESCRIBED
For patients with hepatic impairment, Dyronib 50mg tablets are considered safe without requiring any modification to the prescribed dosage.
What if you forget to take Dyronib 50mg Tablet :
Omit any missed Dyronib 50mg Tablet dose and resume your regular dosing regimen. Avoid taking a double dose.
Facts to Know About Dyronib 50mg Tablet
| Label | Value |
|---|---|
| Chemical Type | Pyrimidine and Thiazole Derivatives |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
| Action Class | TKIs (tyrosine kinase inhibitors) |
3,018 People bought this recently